10-62204944-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145307.4(RTKN2):āc.1099C>Gā(p.Gln367Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000872 in 1,604,784 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_145307.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RTKN2 | NM_145307.4 | c.1099C>G | p.Gln367Glu | missense_variant | 10/12 | ENST00000373789.8 | NP_660350.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RTKN2 | ENST00000373789.8 | c.1099C>G | p.Gln367Glu | missense_variant | 10/12 | 1 | NM_145307.4 | ENSP00000362894 | P1 | |
RTKN2 | ENST00000315289.6 | c.505C>G | p.Gln169Glu | missense_variant | 6/9 | 2 | ENSP00000325379 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000785 AC: 19AN: 242096Hom.: 0 AF XY: 0.0000687 AC XY: 9AN XY: 131066
GnomAD4 exome AF: 0.0000888 AC: 129AN: 1452642Hom.: 0 Cov.: 30 AF XY: 0.0000900 AC XY: 65AN XY: 722314
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2021 | The c.1099C>G (p.Q367E) alteration is located in exon 10 (coding exon 10) of the RTKN2 gene. This alteration results from a C to G substitution at nucleotide position 1099, causing the glutamine (Q) at amino acid position 367 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at